The civic record
Read. Follow. Verify.Nevada Bill Prohibits Health Plans from Requiring Step Therapy for HIV and Hepatitis C Drugs
Last action · June 3, 2025: (No further action taken.)Sponsors: Jeff Stone and 3 others
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Proposed
Senate Bill 354 prohibits certain public and private health insurance plans, including Medicaid, from requiring before covering FDA-approved prescription drugs that prevent the acquisition of HIV or treat HIV and hepatitis C. The measure takes full effect on January 1, 2026.
Who It Would Have Affected
Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.
health insurance policyholders
Policyholders gain guaranteed coverage without step therapy for FDA-approved prescription drugs that prevent HIV acquisition or treat HIV and hepatitis C.
Medicaid recipients
Medicaid recipients are exempted from step therapy protocols when prescribed drugs used to prevent HIV acquisition or treat HIV or hepatitis C.
health insurers
Health insurers and carriers are prohibited from applying step therapy or medical management techniques to specified HIV and hepatitis C prescription drug benefits.
pharmacists
Participating pharmacists providing specified services must be reimbursed at a rate equal to that provided to physicians, physician assistants, or advanced practice registered nurses.
Key Facts
- Insurers offering health insurance, group health insurance, health benefit plans, benefit contracts, hospital or medical services policies, health maintenance organization plans, and managed care plans must cover all FDA-approved drugs for preventing HIV acquisition or treating HIV or hepatitis C without regard to formulary status.
- Health plans are prohibited from subjecting required HIV and hepatitis C drug benefits to medical management techniques such as step therapy.
- Insurers are prohibited from limiting the covered amount of these specified prescription drugs.
- Insurers cannot refuse to cover these drugs because they are dispensed through a mail order service.
Show all 9 facts
- Insurers cannot prohibit or restrict access to any service or drug to treat HIV or hepatitis C on the same day the insured is diagnosed.
- Policies delivered, issued for delivery, or renewed on or after January 1, 2026, automatically include these coverage requirements, and conflicting provisions are void.
- The Medicaid program and other specified health plans are prohibited from applying step therapy protocols to drugs used to prevent HIV acquisition or treat HIV or hepatitis C.
- Pharmacists participating in a network plan must be reimbursed for specified services at a rate equal to the rate provided to a physician, physician assistant, or advanced practice registered nurse.
- Local government additional expenses related to the act are exempted from the limitations of NRS 354.599.
Frequently Asked Questions
What health insurance plans are affected by this bill?
Can insurers refuse to cover HIV or hepatitis C drugs if obtained via mail order?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
This bill did not become law - Died at adjournment · in Senate committee.
Procedural history
6 actions- Jun 3, 2025(No further action taken.)
- Apr 25, 2025CommitteeFrom printer. To engrossment. Engrossed. First reprint. To committee.
- Apr 22, 2025CommitteeNotice of eligibility for exemption. Taken from General File. Re-referred to Committee on Finance. Exemption effective. To printer.
- Apr 21, 2025From committee: Amend, and do pass as amended. Placed on Second Reading File. Read second time. Amended. (Amend. No. 315.) Reprinting dispensed with.
- Mar 17, 2025CommitteeFrom printer. To committee.
- Mar 13, 2025IntroducedRead first time. Referred to Committee on Commerce and Labor. To printer.
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Elimination of Step Therapy for Critical Infectious Disease Medications
The legislation systematically removes step therapy exemptions across multiple chapters of Nevada law governing different types of health plans, Medicaid, and managed care organizations.
Connected Entities
Sources
www.leg.state.nv.us
Analysis Score
0–100- Significance20Lowered because this bill did not pass (its text scored 75)
- Controversy40Intensity of disagreement among stakeholders
- Entertainment10Compellingness for a non-policy-wonk reader
- Buzz30Current news / social attention level
Publisher tools
